Millendo Therapeutics, Inc. (MLND): Price and Financial Metrics


Millendo Therapeutics, Inc. (MLND): $2.16

0.10 (+4.85%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MLND Stock Summary

  • Millendo Therapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 7.5% of US listed stocks.
  • With a year-over-year growth in debt of 570.28%, Millendo Therapeutics Inc's debt growth rate surpasses 96.28% of about US stocks.
  • As for revenue growth, note that MLND's revenue has grown -150.17% over the past 12 months; that beats the revenue growth of only 0.32% of US companies in our set.
  • MLND's SEC filings can be seen here. And to visit Millendo Therapeutics Inc's official web site, go to www.ovascience.com.

MLND Stock Price Chart Interactive Chart >

Price chart for MLND

MLND Price/Volume Stats

Current price $2.16 52-week high $9.67
Prev. close $2.06 52-week low $1.26
Day low $2.10 Volume 333,559
Day high $2.20 Avg. volume 827,243
50-day MA $2.12 Dividend yield N/A
200-day MA $1.89 Market Cap 41.04M

Millendo Therapeutics, Inc. (MLND) Company Bio


Millendo Therapeutics, Inc. provides health care services. The Company develops treatments for endocrine diseases. Millendo Therapeutics serves customers in the United States and France.


MLND Latest News Stream


Event/Time News Detail
Loading, please wait...

MLND Latest Social Stream


Loading social stream, please wait...

View Full MLND Social Stream

Latest MLND News From Around the Web

Below are the latest news stories about Millendo Therapeutics Inc that investors may wish to consider to help them evaluate MLND as an investment opportunity.

Millendo Therapeutics (NASDAQ:MLND) Will Have To Spend Its Cash Wisely

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Yahoo | October 26, 2020

Millendo Therapeutics Reports Second Quarter 2020 Operating and Financial Results

Millendo Therapeutics Reports Second Quarter 2020 Operating and Financial Results

Yahoo | August 10, 2020

Millendo Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference

Millendo Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference

Yahoo | August 5, 2020

Millendo Therapeutics, Inc. (MLND): Hedge Funds Were Caught Flatfooted

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. […]

Yahoo | July 2, 2020

Millendo Therapeutics Provides Corporate and Pipeline Update

Millendo Therapeutics Provides Corporate and Pipeline Update.

Yahoo | June 23, 2020

Read More 'MLND' Stories Here

MLND Price Returns

1-mo 9.64%
3-mo 24.14%
6-mo 27.06%
1-year -71.91%
3-year -85.15%
5-year -97.94%
YTD 0.93%
2020 -68.25%
2019 -15.22%
2018 -62.14%
2017 -8.50%
2016 -84.34%

Continue Researching MLND

Want to see what other sources are saying about Millendo Therapeutics Inc's financials and stock price? Try the links below:

Millendo Therapeutics Inc (MLND) Stock Price | Nasdaq
Millendo Therapeutics Inc (MLND) Stock Quote, History and News - Yahoo Finance
Millendo Therapeutics Inc (MLND) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.9645 seconds.